Roche Aktie

274.50 CHF -1.80CHF -0.65%
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>

Aktionärsstruktur

Inhaber in %
Freefloat 98.83
The Vanguard Group, Inc. 2.86
Norges Bank Investment Management 2.63
Fidelity Management & Research Co. 1.71
UBS AG (Investment Management) 1.69
BlackRock Fund Advisors 1.44
Roche Holding AG 1.15
Zürcher Kantonalbank (Investment Management) 1.05
Dodge & Cox 0.90
Massachusetts Financial Services Co. 0.89
Credit Suisse Asset Management (Schweiz) AG 0.86
PRIMECAP Management Co. 0.82
Alecta Pension Insurance Mutual 0.80
FIL Investment Advisors (UK) Ltd. 0.73
BlackRock Advisors (UK) Ltd. 0.59

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2014 2015 2016 2017 2018
Personal am Ende des Jahres 88'509 91'747 94'052 93'734 94'442
Umsatz pro Mitarbeiter in Mio. EUR 0.54 0.52 0.54 0.57 0.60

Bilanz (in Mio. EUR) - Aktiva

2014 2015 2016 2017 2018
Summe Umlaufvermögen 31'114 28'182 28'670 31'572 32'244
Summe Anlagevermögen 45'300 44'230 46'266 45'401 46'392
Summe Aktiva 75'641 75'763 76'819 76'676 78'517

Bilanz (in Mio. EUR) - Passiva

2014 2015 2016 2017 2018
Gesamtverschuldung/ -verbindlichkeiten 25'714 23'251 22'355 18'960 18'770
Summe Fremdkapital 54'083 52'463 50'417 47'669 48'151
Summe Eigenkapital 21'558 23'300 26'402 29'007 30'366
Summe Passiva 75'641 75'763 76'819 76'676 78'517

Adresse

Grenzacherstrasse 124, 4070 Basel
Telefon 41616881111
Fax 41616919391
Internet http://www.roche.com

Management

Alan Hippe, PhD
Chief Financial & Information Technology Officer
Andreas Oeri, MD
Independent Non-Executive Director
André S. Hoffmann, MBA
Vice Chairman
Anita Hauser, MBA
Director
Beatrice Hau
Investor Relations Coordinator
Bernard J. Poussot
Non-Executive Director
Birgit Masjost, PhD
Investor Relations Officer
Bruno Eschli, PhD
Investor Relations Officer
Christoph Franz, PhD
Chairman
Claudia Süssmuth Dyckerhoff PhD, MBA
Director
Cristina A. Wilbur
Head-Group Human Resources
Eva Losert
Investor Relations Coordinator
Gallia Levy MD, PhD
Associate Group Medical Director-Hematology
Gottlieb A. Keller, LLD
Secretary & General Counsel
Hans Clevers, PhD
Director
Jason S. Ehrlich
Senior Group Medical Director
John Irving Bell, MD
Non-Executive Director
Julie Brown
Director
Karl Mahler, PhD
Head-Investor Relations
Karsten Jung
Global Product Strategy Head
Melanie Wolf
Investor Relations Coordinator
Michael D. Varney, PhD
Head-Genentech Research & Early Development
Nicolas Dunant, PhD
Head-Media Relations
Pablo Umaña, PhD
Head-Cancer Immunotherapy Discovery
Paul Bulcke
Non-Executive Director
Per-Olof Attinger, MBA
Secretary-Executive Committee & Head-CEO Office
Peter R. Voser
Non-Executive Director
Richard P. Lifton MD, PhD
Non-Executive Director
Sabine Borngräber
Investor Relations Officer
Severin Schwan, LLD
Chief Executive Officer & Executive Director
Stephan Feldhaus, PhD
Head-Group Communications
Urs Jaisli, PhD
Chief Compliance Officer
William Pao MD, PhD
Head-Pharma Research & Early Development

Eintrag hinzufügen